Amerant Bancorp (US:AMTB)2021-05-06 16:00Financial Performance - Net income for the three months ended March 31, 2021, was $14,459 thousand, a substantial increase from $3,382 thousand for the same period in 2020, representing a growth of approximately 327%[8] - Basic earnings per common share for the three months ended March 31, 2021, were $0.38, compared to $0.08 for the same period in 2020, indicating a significant improvement in profitability per share[10] - Net interest income for the three months ended March 31, 2021, was $47,569 thousand, compared to $49,229 thousand for the same period in 2020, reflecting a decrease of approximately 3.4%[8] - Noninterest income for the three months ended March 31, 2021, was $14,163 thousand, down from $21,910 thousand for the same period in 2020, a decrease of approximately 35.4%[8] - Total noninterest expenses for the three months ended March 31, 2021, were $43,625 thousand, slightly lower than $44,867 thousand for the same period in 2020, a decrease of about 2.8%[8] Assets and Liabilities - Total assets as of March 31, 2021, were $7,751,098 thousand, a slight decrease from $7,770,893 thousand as of December 31, 2020[6] - Total liabilities as of March 31, 2021, were $6,966,084, a slight decrease from $6,987,472 on December 31, 2020[6] - Total stockholders' equity as of March 31, 2021, was $785,014 thousand, a slight increase from $783,421 thousand as of December 31, 2020[6] - Cash and cash equivalents at the end of the period on March 31, 2021, were $233,499,000, down from $271,053,000 at the end of March 31, 2020[21] - The total investment in loans, net of unearned income, was $5,753,794 thousand, reflecting an increase from $5,668,327 thousand, which is a growth of 1.5%[70] Loan Performance - Provision for loan losses was $0 for the three months ended March 31, 2021, compared to $22,000 thousand for the same period in 2020, indicating a significant reduction in expected credit losses[8] - The allowance for loan losses as of March 31, 2021, was $110,940 thousand, a marginal increase from $110,902 thousand as of December 31, 2020[6] - The total past due loans amounted to $81.2 million as of March 31, 2021, with 90 days or more past due loans totaling $746,000[62] - The total classified loans amounted to $61.837 million, with $29.493 million classified as loss[80] - The total loan portfolio amounted to $5.75 billion as of March 31, 2021, a decrease from $5.84 billion as of December 31, 2020[58] Stock and Equity - The Company approved a stock repurchase program for up to $40 million of Class B common stock on March 10, 2021[27] - The Company repurchased 116,037 shares of Class B common stock at a weighted average price of $15.98, totaling approximately $1.9 million[132] - The Company granted 196,015 restricted stock awards during the three months ended March 31, 2021, with a weighted-average grant date fair value of $16.65 per share[111] - The total unamortized deferred compensation expense for unvested restricted stock as of March 31, 2021, is $3.7 million, to be recognized over 1.7 years[112] - The Company had two swap participation agreements with total notional amounts of approximately $32.0 million as of March 31, 2021, to manage credit risk exposure on certain interest rate swaps[98] Economic Impact and Uncertainty - The COVID-19 pandemic has significantly impacted economic activity, creating uncertainty regarding future financial performance[36] - The Company cannot predict the future impact of COVID-19 on its financial statements due to ongoing economic uncertainty[36] - The Company has made significant estimates regarding loan loss allowances and fair values of securities, which could differ from actual results[35] - The Company has not recognized any significant effects from subsequent events in its interim consolidated financial statements[42] - The Company has implemented practical expedients in lease accounting, excluding short-term leases from recognition[40]